CS257276B2 - Production method substituted 3,4-diamino-1,2,5thiadiazoles - Google Patents
Production method substituted 3,4-diamino-1,2,5thiadiazoles Download PDFInfo
- Publication number
- CS257276B2 CS257276B2 CS854247A CS424785A CS257276B2 CS 257276 B2 CS257276 B2 CS 257276B2 CS 854247 A CS854247 A CS 854247A CS 424785 A CS424785 A CS 424785A CS 257276 B2 CS257276 B2 CS 257276B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- formula
- compound
- compounds
- reaction
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS864232A CS257287B2 (cs) | 1984-06-22 | 1985-06-12 | Způsob výroby N-/2-[2-guanidinothiazol-4-yl)mathylthioJethyl/ethandiimidamidů |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/623,588 US4644006A (en) | 1984-06-22 | 1984-06-22 | Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity |
Publications (2)
Publication Number | Publication Date |
---|---|
CS424785A2 CS424785A2 (en) | 1987-09-17 |
CS257276B2 true CS257276B2 (en) | 1988-04-15 |
Family
ID=24498651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS854247A CS257276B2 (en) | 1984-06-22 | 1985-06-12 | Production method substituted 3,4-diamino-1,2,5thiadiazoles |
Country Status (33)
Country | Link |
---|---|
US (1) | US4644006A (de) |
JP (2) | JPS6118775A (de) |
KR (1) | KR900004321B1 (de) |
AR (1) | AR240935A1 (de) |
AT (1) | AT390790B (de) |
AU (2) | AU580605B2 (de) |
BE (1) | BE902724A (de) |
CA (2) | CA1267412A (de) |
CH (1) | CH665210A5 (de) |
CS (1) | CS257276B2 (de) |
DD (1) | DD240889A5 (de) |
DE (1) | DE3522101A1 (de) |
DK (1) | DK282885A (de) |
ES (2) | ES8702902A1 (de) |
FI (1) | FI852405L (de) |
FR (1) | FR2566406B1 (de) |
GB (2) | GB2161157B (de) |
GR (1) | GR851514B (de) |
HU (1) | HU193992B (de) |
IE (2) | IE58261B1 (de) |
IL (1) | IL75567A0 (de) |
IT (1) | IT1190372B (de) |
LU (1) | LU85969A1 (de) |
NL (1) | NL8501766A (de) |
NO (1) | NO161856C (de) |
NZ (1) | NZ212403A (de) |
OA (1) | OA08039A (de) |
PT (1) | PT80684B (de) |
SE (1) | SE464305B (de) |
SU (1) | SU1537136A3 (de) |
YU (2) | YU45725B (de) |
ZA (1) | ZA854710B (de) |
ZW (1) | ZW10385A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0535227A4 (en) * | 1990-05-29 | 1993-08-18 | Nippon Soda Co., Ltd. | N-substituted heterocyclic amidine derivative |
WO2022034121A1 (en) | 2020-08-11 | 2022-02-17 | Université De Strasbourg | H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3657237A (en) * | 1968-05-22 | 1972-04-18 | Frosst & Co Charles E | Process for making 1 2 5-thiadiazoles in the sinister configuration |
NL189197C (nl) * | 1979-09-04 | 1993-02-01 | Bristol Myers Squibb Co | 3,4-digesubstitueerde-1,2,5-thiadiazool-1-oxiden en 1,1-dioxiden, bereiding daarvan alsmede farmaceutische preparaten. |
DE3175201D1 (en) * | 1980-04-30 | 1986-10-02 | Merck & Co Inc | Aminothiadiazoles as gastric secretion inhibitors |
US4394508A (en) * | 1980-06-07 | 1983-07-19 | Bristol-Myers Company | Chemical compounds |
EP0045155B1 (de) * | 1980-07-30 | 1985-01-02 | Imperial Chemical Industries Plc | Guanidinderivate |
EP0060730A3 (de) * | 1981-03-18 | 1982-12-08 | Imperial Chemical Industries Plc | Bicyclische Derivate |
EP0065823A1 (de) * | 1981-05-13 | 1982-12-01 | Imperial Chemical Industries Plc | Heterozyklische Guanidinderivate als Histamin-H-2-Antagonisten |
US4528375A (en) * | 1982-03-29 | 1985-07-09 | Bristol-Myers Company | Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity |
US4517366A (en) * | 1982-03-29 | 1985-05-14 | Bristol-Myers Company | Intermediates for preparing 3,4-diamino-1,2,5-thiadiazoles |
US4588826A (en) * | 1982-03-29 | 1986-05-13 | Bristol-Myers Company | Ethanediimidamide intermediates |
US4528377A (en) * | 1982-03-29 | 1985-07-09 | Bristol-Myers Company | Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity |
NL8301063A (nl) * | 1982-03-29 | 1983-10-17 | Bristol Myers Co | Gesubstitueerde 3,4-diamino-1,2,5-thiadiazolen met histamine h2-receptor antagonistische werkzaamheid; gesubstitueerde ethaandiimidamiden. |
US4528378A (en) * | 1982-03-29 | 1985-07-09 | Bristol-Myers Company | Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity |
FI832519L (fi) * | 1982-07-12 | 1984-01-13 | Bristol Myers Co | Farmaceutiska foerfaranden och sammansaettningar |
US4520025A (en) * | 1982-07-21 | 1985-05-28 | William H. Rorer, Inc. | Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses |
JPS5978171A (ja) * | 1982-10-26 | 1984-05-04 | Ikeda Mohandou:Kk | 複素環式化合物 |
US4440933A (en) * | 1983-03-16 | 1984-04-03 | Bristol-Myers Company | Process for preparing 1,2,5-thiadiazoles |
-
1984
- 1984-06-22 US US06/623,588 patent/US4644006A/en not_active Expired - Fee Related
-
1985
- 1985-06-05 SU SU853906050A patent/SU1537136A3/ru active
- 1985-06-07 CA CA000483419A patent/CA1267412A/en not_active Expired - Lifetime
- 1985-06-07 FR FR8508668A patent/FR2566406B1/fr not_active Expired
- 1985-06-12 CS CS854247A patent/CS257276B2/cs unknown
- 1985-06-13 NZ NZ212403A patent/NZ212403A/xx unknown
- 1985-06-17 FI FI852405A patent/FI852405L/fi not_active Application Discontinuation
- 1985-06-19 NL NL8501766A patent/NL8501766A/nl not_active Application Discontinuation
- 1985-06-19 DD DD85277533A patent/DD240889A5/de not_active IP Right Cessation
- 1985-06-19 AR AR300752A patent/AR240935A1/es active
- 1985-06-19 IL IL75567A patent/IL75567A0/xx not_active IP Right Cessation
- 1985-06-20 IT IT21217/85A patent/IT1190372B/it active
- 1985-06-20 SE SE8503110A patent/SE464305B/sv not_active IP Right Cessation
- 1985-06-20 GR GR851514A patent/GR851514B/el unknown
- 1985-06-20 DE DE19853522101 patent/DE3522101A1/de not_active Withdrawn
- 1985-06-20 KR KR1019850004457A patent/KR900004321B1/ko not_active IP Right Cessation
- 1985-06-21 IE IE155785A patent/IE58261B1/en not_active IP Right Cessation
- 1985-06-21 BE BE0/215242A patent/BE902724A/fr not_active IP Right Cessation
- 1985-06-21 LU LU85969A patent/LU85969A1/fr unknown
- 1985-06-21 AU AU43920/85A patent/AU580605B2/en not_active Ceased
- 1985-06-21 HU HU852443A patent/HU193992B/hu not_active IP Right Cessation
- 1985-06-21 ZA ZA854710A patent/ZA854710B/xx unknown
- 1985-06-21 NO NO852519A patent/NO161856C/no unknown
- 1985-06-21 PT PT80684A patent/PT80684B/pt not_active IP Right Cessation
- 1985-06-21 AT AT0185885A patent/AT390790B/de not_active IP Right Cessation
- 1985-06-21 JP JP60135861A patent/JPS6118775A/ja active Pending
- 1985-06-21 ES ES544409A patent/ES8702902A1/es not_active Expired
- 1985-06-21 CH CH2657/85A patent/CH665210A5/de not_active IP Right Cessation
- 1985-06-21 IE IE501/89A patent/IE57937B1/en not_active IP Right Cessation
- 1985-06-21 GB GB08515749A patent/GB2161157B/en not_active Expired
- 1985-06-21 DK DK282885A patent/DK282885A/da unknown
- 1985-06-21 ZW ZW103/85A patent/ZW10385A1/xx unknown
- 1985-06-24 YU YU105185A patent/YU45725B/sh unknown
- 1985-08-18 OA OA58614A patent/OA08039A/xx unknown
- 1985-10-04 JP JP60221721A patent/JPS61186369A/ja active Pending
-
1986
- 1986-01-31 ES ES551506A patent/ES8702881A1/es not_active Expired
-
1987
- 1987-06-03 YU YU102587A patent/YU45822B/sh unknown
- 1987-07-09 GB GB08716149A patent/GB2192884B/en not_active Expired
-
1989
- 1989-02-08 AU AU29775/89A patent/AU614331B2/en not_active Ceased
- 1989-05-12 CA CA000599622A patent/CA1297875C/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4639523A (en) | Aminoalkylphenoxy derivatives | |
FI78695B (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1,2-diaminocyklobuten-3,4-dionderivat. | |
SU1400508A3 (ru) | Способ получени производных арилтиазолов | |
JPS6028819B2 (ja) | 新規なるグアニジン誘導体の製造方法 | |
JP2502343B2 (ja) | 薬学的に活性な置換ベンズアミド | |
JPH0233031B2 (de) | ||
KR840001075B1 (ko) | 티아졸 유도체의 제조방법 | |
US4210658A (en) | Amidinosulphonic acid derivatives | |
CS241072B2 (en) | Method of 3-/(amino or subst,amino/)-4-/(subst.amino/)-1,2,5-thiadizoles production | |
HU181408B (en) | Process for preparing substituted furan derivatives | |
US4692531A (en) | Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity | |
CS257276B2 (en) | Production method substituted 3,4-diamino-1,2,5thiadiazoles | |
SU1364240A3 (ru) | Способ получени производных 4,5,6,7-тетра-гидротиазоло-(5,4-с)-пиридина или их фармацевтически приемлемых солей | |
HU182645B (en) | Process for preparing n-cyano-n'-2-//4-methyl-5-imidazolyl/-methyl-thio/-ethyl-n''-alkinyl-guanidine | |
EP0189307A2 (de) | Antihistamin-H2 Alkyn Thiadiazolderivate | |
KR880002209B1 (ko) | 치환된 3,4-디아미노-1,2,5-티아디아졸류 및 그의 제조방법 | |
GB1598628A (en) | Guanidine derivatives | |
US4200760A (en) | Imidazolylalkylthioalkylamino-ethylene derivatives | |
US4543352A (en) | Naphthalene aminoalkylene ethers and thioethers, and their pharmaceutical uses | |
JPH0680041B2 (ja) | 2−ピリジル酢酸誘導体、その製法およびそれを含む医薬 | |
JPH0572386B2 (de) | ||
CA1297107C (en) | Process for the preparation of new 2-(2-thienyl)- imidazo(4,5-c)pyridine derivatives and pharmaceutically usable acid addition salts thereof | |
KR810000632B1 (ko) | 히스타민 h₂수용기 길항제 또는 비독성인 그의 약조제 가능한 산 첨가염의 제조방법 | |
DE3441086A1 (de) | 3,4-diazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
KR880002530B1 (ko) | 치환된 에탄디이미드 아미드 및 그의 제조방법 |